Cost-effectiveness analysis of bimekizumab for the treatment of active psoriatic arthritis in Sweden-Reference-Cited by-同舟云学术

Cost-effectiveness analysis of bimekizumab for the treatment of active psoriatic arthritis in Sweden

Published:2023-09-15 Issue:1 Volume:26 Page:1190-1200
ISSN:1369-6998
Container-title:Journal of Medical Economics
language:en
Short-container-title:Journal of Medical Economics

Author:

Sigurdardottir Valgerdur¹^ORCID,Engstrom Anna²,Berling Patric²,Olofsson Tor³^ORCID,Oldsberg Linnea⁴^ORCID,Sadler Susannah⁵^ORCID,Parra-Padilla Devian⁶^ORCID,Melis Lode⁷,Willems Damon⁷^ORCID

Affiliation:

1. Department of Rheumatology, Falun Hospital, Centre for Clinical Research, Dalarna, Uppsala University, Falun, Sweden

2. UCB Pharma, Stockholm, Sweden

3. Department of Rheumatology, Lund University

4. Quantify Research, Stockholm, Sweden

5. Cytel, London, England, United Kingdom

6. Cytel, Rotterdam, Netherlands

7. UCB Pharma, Brussels, Belgium

Funder

UCB Pharma

Publisher

Informa UK Limited

Subject

Health Policy

Link

https://www.tandfonline.com/doi/pdf/10.1080/13696998.2023.2259609

Reference57 articles.

1. Clinical Features of Psoriatic Arthritis: a Comprehensive Review of Unmet Clinical Needs

2. Psoriatic Arthritis

3. The National Prevalence of Clinically Diagnosed Psoriatic Arthritis in Sweden in 2017

4. Statistics Sweden. Official Statistics of Sweden: population: statistics Sweden; 2022 [cited 2023 28/07/2023]. Available from: https://www.statistikdatabasen.scb.se/pxweb/en/ssd/START__BE/.

5. Incidence of Psoriatic Arthritis in Patients with Skin Psoriasis and Associated Risk Factors: A Retrospective Population-based Cohort Study in Swedish Routine Clinical Care

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cost and Cost Effectiveness of Treatments for Psoriatic Arthritis: An Updated Systematic Literature Review;PharmacoEconomics;2024-08-24